Cadrenal Therapeutics Inc. Common Stock (CVKD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cadrenal Therapeutics Inc...

    NASDAQ: CVKD · Real-Time Price · USD
    14.31
    0.12 (0.85%)
    At close: Oct 03, 2025, 3:59 PM
    14.36
    0.35%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Cadrenal Therapeutics Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Net Income
    		 -10.65M -8.36M -6.71M
    Depreciation & Amortization
    		 1.88K 1.98K 1.27K
    Stock-Based Compensation
    		 1.42M 710.38K n/a
    Other Working Capital
    		 538.1K 381.89K 202.84K
    Other Non-Cash Items
    		 -352 3.97M 4.5M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 1.87M 144.31K 607.74K
    Operating Cash Flow
    		 -7.36M -3.53M -1.2M
    Capital Expenditures
    		 -6.54K -3.25K n/a
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 n/a n/a -2.28K
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 -6.54K -3.25K -2.28K
    Debt Repayment
    		 n/a -250K n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 3.84M 250K n/a
    Financial Cash Flow
    		 8.98M 11.9M 1.24M
    Net Cash Flow
    		 1.62M 8.37M 32.59K
    Free Cash Flow
    		 -7.36M -3.53M -1.2M

    Add to Watchlist